Background: Limited studies on atopic dermatitis (AD) have investigated the possible covariance of sociodemographic factors with the Hospital Anxiety and Depression Scale (HADS).
Objective: This study aimed to examine the possible covariance between AD severity and HADS scores of patients in Taiwan.
Methods: Patients with AD from a medical center and 2 regional hospitals in Taiwan were enrolled in this cross-sectional study from April 2018 to April 2019. AD severity was measured using the "scoring atopic dermatitis" index, and anxiety and depression were screened based on HADS.
Results: A total of 200 patients were included. After correcting for sociodemographic variables, significantly more borderline (≥8) and abnormal (≥11) cases of anxiety/depression (P < .05) were noted in patients with moderate-to-severe AD.
Limitations: First, the cross-sectional study design cannot show causality. Second, baseline data, including a history of underlying cancer or previous psychiatric disorder, were not obtained in the questionnaire and may confound the HADS scores. Finally, a standardized psychiatric clinical interviews study design should be used for higher accuracy in the assessment of psycho-comorbidities.
Conclusion: Higher anxiety and depression risks were noted in patients with moderate-to-severe AD. Except for psychosomatic symptoms, all kinds of anxiety and depression symptoms occurred more frequently in patients with moderate-to-severe AD.
Keywords: AD, atopic dermatitis; BMI, body mass index; HADS; HADS, Hospital Anxiety and Depression Scale; HADS-A, Hospital Anxiety and Depression Scale–anxiety; HADS-D, Hospital Anxiety and Depression Scale–depression; HADS-T, total Hospital Anxiety and Depression Scale; Hospital Anxiety and Depression Scale; SCORAD; SCORAD, scoring atopic dermatitis; anxiety; atopic dermatitis; depression; psycho-comorbidities.
© 2022 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.